XML 78 R63.htm IDEA: XBRL DOCUMENT v3.8.0.1
Intangible Assets (Narrative) (Details)
$ in Thousands
 1 Months Ended 3 Months Ended 11 Months Ended 12 Months Ended
Dec. 30, 2016
USD ($)
Jul. 07, 2016
USD ($)
Dec. 31, 2016
USD ($)
Aug. 31, 2016
USD ($)
Dec. 31, 2014
USD ($)
Mar. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Sep. 30, 2017
USD ($)
Jun. 30, 2017
USD ($)
Mar. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Sep. 30, 2016
USD ($)
Jun. 30, 2016
USD ($)
Feb. 28, 2018
USD ($)
trade_name
Mar. 31, 2018
USD ($)
Mar. 31, 2017
USD ($)
Mar. 31, 2016
USD ($)
Jan. 26, 2017
USD ($)
Feb. 05, 2016
USD ($)
Schedule of Intangible Assets [Line Items]                                      
Proceeds from divestitures                             $ 0 $ 110,717 $ 0    
Loss on divestitures                   $ 268 $ (3,405) $ (496) $ 55,453   0 51,820 0    
Number of indefinite-lived trade names exceeding carrying value by less than 10% | trade_name                           2          
Impairment of finite-lived assets           $ 99,924 $ 0 $ 0 $ 0           $ 99,924 0 $ 0    
Finite-lived intangible assets, weighted average remaining period                             12 years 5 months 24 days        
Amortization of intangible assets                             $ 23,300 19,753      
Minimum                                      
Schedule of Intangible Assets [Line Items]                                      
Intangible assets, useful lives                             10 years        
Maximum                                      
Schedule of Intangible Assets [Line Items]                                      
Intangible assets, useful lives                             30 years        
Cost of capital                                      
Schedule of Intangible Assets [Line Items]                                      
Increase (decrease) in fair value measurement input                           0.0050          
Impact of change in measurement input on indefinite-lived asset impairment                           $ 4,200          
Massengill brand                                      
Schedule of Intangible Assets [Line Items]                                      
Impairment of finite-lived assets                             $ 600        
Tradenames                                      
Schedule of Intangible Assets [Line Items]                                      
Indefinite-lived intangibles, reductions       $ 9,000                              
Tradenames | Terminal growth rate                                      
Schedule of Intangible Assets [Line Items]                                      
Increase (decrease) in fair value measurement input                           (0.0050)          
Impact of change in measurement input on indefinite-lived asset impairment                           $ 2,300          
Beano Brand                                      
Schedule of Intangible Assets [Line Items]                                      
Impairment of indefinite-lived assets                             28,600        
Tradenames                           49,800          
Comet Brand                                      
Schedule of Intangible Assets [Line Items]                                      
Indefinite-lived intangibles, reductions       9,000                              
Proceeds from the sale of property and equipment       11,000 $ 10,000                            
Agreement election amount per quarter                 $ 1,000                    
Gain on sale of asset       $ 1,200                              
Impairment of indefinite-lived assets                             $ 70,700        
Tradenames                           $ 30,600          
Disposal group, disposed of by sale, not discontinued operations | Pediacare, New Skin and Fiber Choice | North American OTC Healthcare | Cough and Cold, Dermatologicals, and Gastrointestinal products group                                      
Schedule of Intangible Assets [Line Items]                                      
Consideration, excluding costs of inventory   $ 40,000                                  
Proceeds from divestitures   40,100                                  
Indefinite-lived intangibles, reductions   37,200                                  
Finite-lived intangible assets, written off   $ 54,000                                  
Loss on divestitures                               $ 56,200      
Disposal group, disposed of by sale, not discontinued operations | Dermoplast | North American OTC Healthcare | Cough and Cold, Dermatologicals, and Gastrointestinal products group                                      
Schedule of Intangible Assets [Line Items]                                      
Proceeds from divestitures $ 48,400                                    
Indefinite-lived intangibles, reductions $ 31,000                                    
Disposal group, disposed of by sale, not discontinued operations | E.P.T. | North American OTC Healthcare | Cough and Cold, Dermatologicals, and Gastrointestinal products group                                      
Schedule of Intangible Assets [Line Items]                                      
Indefinite-lived intangibles, reductions     $ 14,800                                
DenTek Oral Care, Inc.                                      
Schedule of Intangible Assets [Line Items]                                      
Intangible assets acquired                                     $ 206,700
C.B. Fleet Company, Inc.                                      
Schedule of Intangible Assets [Line Items]                                      
Intangible assets acquired                                   $ 747,600